Skip to content
HomeMedia CenterPress releases FinancialJohnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference

Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference

Share Article
share to

New Brunswick, NJ (May 2, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1st, at the New York Hilton Midtown in New York. Joaquin Duato, Chief Executive Officer will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com

A webcast replay will be available approximately 48-hrs after the live webcast.

Media Contacts:
Jake Sargent
(732) 524-1090

Investor Contacts:
Sarah Wood
(732) 524-2617

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.